Clinical findings differentiate significant prostate cancer in patients with negative MRI, suggesting improved diagnosis methods.
Clinical predictors of csPCa remain similar among patients with negative mpMRI. MRI BPH and prostatitis along with lower radiologist read volume differentiated FN from TP cases. Enhanced clinical stratification tools and mpMRI refinements could improve confidence in forgoing biopsy for patients with a negative mpMRI.
No takes yet. Share an insight, caveat, or question.
Schnauss et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: